Mybl1: A Protein with Multiple Functions and Potential Drug Targets

Target Name: MYBL1

NCBI ID: G4603

MYBL1

Mybl1: A Protein with Multiple Functions and Potential Drug Targets

Mybl1, also known as MGC120061, is a protein that is expressed in a variety of tissues throughout the body, including the nervous system, muscle system, and blood vessels. It is a member of the mybl gene family, which is known for the production of microglial cells, which are a type of immune cell that play a crucial role in the immune response.

One of the unique features of Mybl1 is its ability to interact with other proteins, particularly the protein known as NF-kappa-B. NF-kappa-B is a protein that plays a role in regulating various cellular processes in the body, including inflammation and cell growth. Mybl1 has been shown to interact with NF-kappa-B and can modulate its activity, which may have implications for the regulation of inflammation and other cellular processes.

In addition to its potential role in modulating NF-kappa-B activity, Mybl1 has also been shown to play a role in the regulation of cell adhesion. Cell adhesion refers to the interaction between cells that results in the formation of tight junctions and adherens junctions, which are structures that help to maintain the integrity of tissues and are critical for various cellular processes, including cell signaling and transport. Mybl1 has been shown to be involved in the regulation of cell adhesion and may be a potential drug target or biomarker for various diseases.

Mybl1 has also been shown to play a role in the regulation of cell survival. Cell survival refers to the ability of cells to continue to exist and function, even in the face of various cellular stressors, such as those that can result from inflammation or other forms of damage. Mybl1 has been shown to be involved in the regulation of cell survival and may be a potential drug target or biomarker for diseases that involve cellular stress or dysfunction.

In conclusion, Mybl1 is a protein that has been shown to play a number of important roles in various cellular processes throughout the body. Its ability to interact with NF-kappa-B and cell adhesion proteins, as well as its role in cell survival, make it a potential drug target or biomarker for a variety of diseases. Further research is needed to fully understand the full range of functions of Mybl1 and to determine its potential as a drug or biomarker.

Protein Name: MYB Proto-oncogene Like 1

Functions: Transcription factor that specifically recognizes the sequence 5'-YAAC[GT]G-3' (PubMed:8058310, PubMed:7987850). Acts as a master regulator of male meiosis by promoting expression of piRNAs: activates expression of both piRNA precursor RNAs and expression of protein-coding genes involved in piRNA metabolism (By similarity). The piRNA metabolic process mediates the repression of transposable elements during meiosis by forming complexes composed of piRNAs and Piwi proteins and governs the methylation and subsequent repression of transposons, which is essential for the germline integrity (By similarity). Transcriptional activator of SOX30 (By similarity)

The "MYBL1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MYBL1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets